Work

Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability

Year: 2012
Type: article
Abstract: Results of a study, published in this issue of The Oncologist, comparing capecitabine and oxaliplatin plus bevacizumab with the same regimen for only six cycles followed by bevacizumab monotherapy in metastatic colorectal cancer patients are examined.
Institution: Duke Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2145753255
FWCI: 0.632
Cites: 6
Cited by: 8
Related to: 10